speb/financial-data huggingface dataset:
ONL balance_sheet (quarterly, 2026-03-31) — Other Properties: 23667000.00
ONL income_statement (quarterly, 2026-03-31) — Other Special Charges: 244000.00
ONL balance_sheet (quarterly, 2026-03-31) — Payables: 4169000.00
ONL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 36455000.00
ONL balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3656000.00
ONL income_statement (quarterly, 2026-03-31) — Pretax Income: -13497000.00
ONL cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -439000.00
ONL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -14438000.00
ONL balance_sheet (quarterly, 2026-03-31) — Receivables: 47644000.00
ONL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14783000.00
ONL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 13159000.00
ONL cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -112722000.00
ONL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -619000.00
ONL balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 50259000.00
ONL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -543432000.00
ONL cash_flow (quarterly, 2026-03-31) — Sale Of Investment Properties: 13453000.00
ONL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5140000.00
ONL balance_sheet (quarterly, 2026-03-31) — Share Issued: 56830068.00
ONL cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 18000000.00
ONL income_statement (quarterly, 2026-03-31) — Special Income Charges: -6540000.00
ONL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 868000.00
ONL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 608517000.00
ONL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 526826000.00
ONL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2616000.00
ONL income_statement (quarterly, 2026-03-31) — Tax Provision: 71000.00
ONL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ONL balance_sheet (quarterly, 2026-03-31) — Total Assets: 1188291000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 975444000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Debt: 493927000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 609790000.00
ONL income_statement (quarterly, 2026-03-31) — Total Expenses: 32902000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 578501000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1076458000.00
ONL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 415046000.00
ONL income_statement (quarterly, 2026-03-31) — Total Unusual Items: -6540000.00
ONL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -6540000.00
ONL balance_sheet (quarterly, 2026-03-31) — Working Capital: -51622000.00
ONMD income_statement (annual, 2021-12-31) — Basic Average Shares: 4033170.00
ONMD income_statement (annual, 2021-12-31) — Basic EPS: -0.73
ONMD cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -23164.00
ONMD income_statement (annual, 2021-12-31) — Diluted Average Shares: 4033170.00
ONMD income_statement (annual, 2021-12-31) — Diluted EPS: -0.73
ONMD balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 0.00
ONMD balance_sheet (annual, 2021-12-31) — Long Term Debt: 1546897.00
ONMD balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 1546897.00
ONMD cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 2494468.00
ONMD balance_sheet (annual, 2021-12-31) — Net Debt: 4197577.00
ONMD balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 287610.00
ONMD income_statement (annual, 2021-12-31) — Other Operating Expenses: 152461.00
ONMD balance_sheet (annual, 2021-12-31) — Preferred Stock Equity: 705.00
ONMD income_statement (annual, 2022-12-31) — +Operating Expense: 15428000.00
ONMD income_statement (annual, 2022-12-31) — +Total Revenue: 1153000.00
ONMD balance_sheet (annual, 2022-12-31) — Accounts Payable: 1177000.00
ONMD balance_sheet (annual, 2022-12-31) — Accounts Receivable: 19000.00
ONMD balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -180000.00
ONMD balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 13657000.00
ONMD balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -125233.00
ONMD income_statement (annual, 2022-12-31) — Basic Average Shares: 4033170.00
ONMD income_statement (annual, 2022-12-31) — Basic EPS: -7.55
ONMD cash_flow (annual, 2022-12-31) — Beginning Cash Position: 699000.00
ONMD cash_flow (annual, 2022-12-31) — Capital Expenditure: -58000.00
ONMD balance_sheet (annual, 2022-12-31) — Capital Stock: 17644000.00
ONMD balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 271000.00
ONMD balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 271000.00
ONMD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 4333000.00
ONMD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -58000.00
ONMD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -4703000.00
ONMD cash_flow (annual, 2022-12-31) — Change In Account Payable: 1929787.00
ONMD cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 120807.00
ONMD cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -958865.00
ONMD cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -458000.00
ONMD cash_flow (annual, 2022-12-31) — Change In Payable: 2062094.00
ONMD cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 415000.00
ONMD cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -59000.00
ONMD cash_flow (annual, 2022-12-31) — Change In Receivables: 73000.00
ONMD cash_flow (annual, 2022-12-31) — Change In Tax Payable: 120807.00
ONMD cash_flow (annual, 2022-12-31) — Change In Working Capital: -29000.00
ONMD cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 73000.00
ONMD cash_flow (annual, 2022-12-31) — Changes In Cash: -428000.00
ONMD balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
ONMD balance_sheet (annual, 2022-12-31) — Common Stock Equity: -44003000.00
ONMD cash_flow (annual, 2022-12-31) — Common Stock Issuance: 2825960.00
ONMD cash_flow (annual, 2022-12-31) — Common Stock Payments: -88549890.00
ONMD income_statement (annual, 2022-12-31) — Cost Of Revenue: 1513000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Assets: 391000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Debt: 24743000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 24743000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 184000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 184000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Liabilities: 26104000.00
ONMD balance_sheet (annual, 2022-12-31) — Current Notes Payable: 0.00
ONMD cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 25000.00
ONMD cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 25000.00
ONMD balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 362558.00
ONMD income_statement (annual, 2022-12-31) — Diluted Average Shares: 4033170.00
ONMD income_statement (annual, 2022-12-31) — Diluted EPS: -7.55
ONMD income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -30451000.00
ONMD balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 900152.00
ONMD income_statement (annual, 2022-12-31) — EBIT: -30434000.00
ONMD income_statement (annual, 2022-12-31) — EBITDA: -30409000.00
ONMD cash_flow (annual, 2022-12-31) — End Cash Position: 271000.00
ONMD cash_flow (annual, 2022-12-31) — Financing Cash Flow: 4333000.00
ONMD cash_flow (annual, 2022-12-31) — Free Cash Flow: -4761000.00
ONMD cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 8073000.00
ONMD income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 4489110.00
ONMD income_statement (annual, 2022-12-31) — General And Administrative Expense: 12879000.00
ONMD balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 144233.00
ONMD balance_sheet (annual, 2022-12-31) — Gross PPE: 263000.00
ONMD income_statement (annual, 2022-12-31) — Gross Profit: -360000.00
ONMD balance_sheet (annual, 2022-12-31) — Income Tax Payable: 214850.00
ONMD income_statement (annual, 2022-12-31) — Interest Expense: 0.00
ONMD income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 0.00
ONMD balance_sheet (annual, 2022-12-31) — Invested Capital: -17760000.00
ONMD cash_flow (annual, 2022-12-31) — Investing Cash Flow: -58000.00
ONMD cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
ONMD cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5140000.00
ONMD balance_sheet (annual, 2022-12-31) — Long Term Debt: 1500000.00
ONMD balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1500000.00
ONMD cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5140000.00
ONMD cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2754.00
ONMD balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 263000.00
ONMD cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -85723930.00
ONMD balance_sheet (annual, 2022-12-31) — Net Debt: 25972000.00
ONMD income_statement (annual, 2022-12-31) — Net Income: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -30451000.00
ONMD cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -30451000.00
ONMD income_statement (annual, 2022-12-31) — Net Interest Income: 0.00
ONMD cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 5140000.00
ONMD cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 5140000.00
ONMD income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 0.00
ONMD cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -815000.00
ONMD balance_sheet (annual, 2022-12-31) — Net PPE: 83000.00
ONMD cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -58000.00
ONMD cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
ONMD balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -26359000.00
ONMD balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 690772.00
ONMD balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 815000.00
ONMD income_statement (annual, 2022-12-31) — Normalized EBITDA: -30409000.00
ONMD income_statement (annual, 2022-12-31) — Normalized Income: -30451000.00
ONMD cash_flow (annual, 2022-12-31) — Operating Cash Flow: -4703000.00
ONMD cash_flow (annual, 2022-12-31) — Operating Gains Losses: 8073000.00
ONMD income_statement (annual, 2022-12-31) — Operating Income: -15788000.00
ONMD income_statement (annual, 2022-12-31) — Operating Revenue: 1153000.00
ONMD balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 32263342.00
ONMD balance_sheet (annual, 2022-12-31) — Other Current Assets: 101000.00
ONMD balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 24743000.00
ONMD balance_sheet (annual, 2022-12-31) — Other Equity Interest: 28750110.00
ONMD income_statement (annual, 2022-12-31) — Other Gand A: 4806000.00
ONMD income_statement (annual, 2022-12-31) — Other Income Expense: -14646000.00
ONMD cash_flow (annual, 2022-12-31) — Other Non Cash Items: 15814000.00
ONMD balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 44000.00
ONMD income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -14646000.00
ONMD income_statement (annual, 2022-12-31) — Other Operating Expenses: 398760.00
ONMD balance_sheet (annual, 2022-12-31) — Payables: 1177000.00
ONMD balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1177000.00
ONMD balance_sheet (annual, 2022-12-31) — Preferred Stock: 17644000.00
ONMD balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 17644000.00
ONMD cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
ONMD income_statement (annual, 2022-12-31) — Pretax Income: -30434000.00
ONMD cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 8000.00
ONMD cash_flow (annual, 2022-12-31) — Purchase Of PPE: -58000.00
ONMD balance_sheet (annual, 2022-12-31) — Receivables: 19000.00
ONMD income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1513000.00
ONMD income_statement (annual, 2022-12-31) — Reconciled Depreciation: 25000.00
ONMD cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2754.00
ONMD cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -88549890.00
ONMD income_statement (annual, 2022-12-31) — Research And Development: 1591000.00
ONMD balance_sheet (annual, 2022-12-31) — Restricted Cash: 29029415.00
ONMD balance_sheet (annual, 2022-12-31) — Retained Earnings: -57660000.00
ONMD income_statement (annual, 2022-12-31) — Salaries And Wages: 8073000.00
ONMD income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 958000.00
ONMD income_statement (annual, 2022-12-31) — Selling General And Administration: 13837000.00
ONMD balance_sheet (annual, 2022-12-31) — Share Issued: 32263342.00
ONMD cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1865000.00
ONMD balance_sheet (annual, 2022-12-31) — Stockholders Equity: -26359000.00
ONMD balance_sheet (annual, 2022-12-31) — Tangible Book Value: -44003000.00
ONMD income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (annual, 2022-12-31) — Tax Provision: 17000.00
ONMD income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
ONMD balance_sheet (annual, 2022-12-31) — Total Assets: 1289000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Capitalization: -24859000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Debt: 26243000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -26359000.00
ONMD income_statement (annual, 2022-12-31) — Total Expenses: 16941000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27648000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 898000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1544000.00
ONMD income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -7715000.00
ONMD balance_sheet (annual, 2022-12-31) — Total Tax Payable: 284816.00
ONMD income_statement (annual, 2022-12-31) — Total Unusual Items: 4489110.00
ONMD income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 4489110.00
ONMD balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 4025000.00
ONMD cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 14616000.00
ONMD balance_sheet (annual, 2022-12-31) — Working Capital: -25713000.00
ONMD income_statement (annual, 2023-12-31) — +Operating Expense: 6724000.00
ONMD income_statement (annual, 2023-12-31) — +Total Revenue: 1021000.00
ONMD balance_sheet (annual, 2023-12-31) — Accounts Payable: 4682000.00
ONMD balance_sheet (annual, 2023-12-31) — Accounts Receivable: 152000.00
ONMD balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -208000.00
ONMD balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 77996000.00
ONMD balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ONMD income_statement (annual, 2023-12-31) — Basic Average Shares: 7271014.00
ONMD income_statement (annual, 2023-12-31) — Basic EPS: -4.65
ONMD cash_flow (annual, 2023-12-31) — Beginning Cash Position: 271000.00
ONMD cash_flow (annual, 2023-12-31) — Capital Expenditure: -44000.00
ONMD balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
ONMD balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 47000.00
ONMD balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 47000.00
ONMD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 4611000.00
ONMD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -44000.00
ONMD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -4791000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Account Payable: 717000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -51446.00
ONMD cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
ONMD cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 70000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Payable: 717000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 717000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -43000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Receivables: -133000.00
ONMD cash_flow (annual, 2023-12-31) — Change In Tax Payable: -51446.00
ONMD cash_flow (annual, 2023-12-31) — Change In Working Capital: 611000.00
ONMD cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -133000.00
ONMD cash_flow (annual, 2023-12-31) — Changes In Cash: -224000.00
ONMD balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
ONMD balance_sheet (annual, 2023-12-31) — Common Stock Equity: -13442000.00
ONMD cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ONMD cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
ONMD income_statement (annual, 2023-12-31) — Cost Of Revenue: 1150000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Assets: 365000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Debt: 5094000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5094000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 254000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 254000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Liabilities: 13838000.00
ONMD balance_sheet (annual, 2023-12-31) — Current Notes Payable: 1637000.00
ONMD cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 28000.00
ONMD cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 28000.00
ONMD balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 24582.00
ONMD income_statement (annual, 2023-12-31) — Diluted Average Shares: 7271014.00
ONMD income_statement (annual, 2023-12-31) — Diluted EPS: -4.65
ONMD income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -33780000.00
ONMD income_statement (annual, 2023-12-31) — EBIT: -33751000.00
ONMD income_statement (annual, 2023-12-31) — EBITDA: -33723000.00
ONMD cash_flow (annual, 2023-12-31) — End Cash Position: 47000.00
ONMD cash_flow (annual, 2023-12-31) — Financing Cash Flow: 4611000.00
ONMD cash_flow (annual, 2023-12-31) — Free Cash Flow: -4835000.00
ONMD cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 9078000.00
ONMD income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -9078000.00
ONMD income_statement (annual, 2023-12-31) — General And Administrative Expense: 3544000.00
ONMD balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 152000.00
ONMD balance_sheet (annual, 2023-12-31) — Gross PPE: 307000.00
ONMD income_statement (annual, 2023-12-31) — Gross Profit: -129000.00
ONMD cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Income Tax Payable: 120017.00
ONMD income_statement (annual, 2023-12-31) — Interest Expense: 11000.00
ONMD income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 11000.00
ONMD cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Invested Capital: -8348000.00
ONMD cash_flow (annual, 2023-12-31) — Investing Cash Flow: -44000.00
ONMD cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 16000.00
ONMD cash_flow (annual, 2023-12-31) — Issuance Of Debt: 6129000.00
ONMD balance_sheet (annual, 2023-12-31) — Long Term Debt: 465000.00
ONMD balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 465000.00
ONMD cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2015373.00
ONMD cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -10680772.00
ONMD balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 307000.00
ONMD cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Net Debt: 5047000.00
ONMD income_statement (annual, 2023-12-31) — Net Income: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -33780000.00
ONMD cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -33780000.00
ONMD income_statement (annual, 2023-12-31) — Net Interest Income: -11000.00
ONMD cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
ONMD cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 6129000.00
ONMD cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -8665399.00
ONMD income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -11000.00
ONMD cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1534000.00
ONMD balance_sheet (annual, 2023-12-31) — Net PPE: 99000.00
ONMD cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -44000.00
ONMD cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 16000.00
ONMD cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 6129000.00
ONMD balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -13442000.00
ONMD balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
ONMD income_statement (annual, 2023-12-31) — Normalized EBITDA: -24645000.00
ONMD income_statement (annual, 2023-12-31) — Normalized Income: -26608380.00
ONMD cash_flow (annual, 2023-12-31) — Operating Cash Flow: -4791000.00
ONMD cash_flow (annual, 2023-12-31) — Operating Gains Losses: 9078000.00
ONMD income_statement (annual, 2023-12-31) — Operating Income: -6853000.00
ONMD income_statement (annual, 2023-12-31) — Operating Revenue: 1021000.00
ONMD balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 23572232.00
ONMD balance_sheet (annual, 2023-12-31) — Other Current Assets: 166000.00
ONMD balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 3457000.00
ONMD balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 283000.00
ONMD income_statement (annual, 2023-12-31) — Other Gand A: 3544000.00
ONMD income_statement (annual, 2023-12-31) — Other Income Expense: -26898000.00
ONMD cash_flow (annual, 2023-12-31) — Other Non Cash Items: 17797000.00
ONMD balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 68000.00
ONMD income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -17820000.00
ONMD income_statement (annual, 2023-12-31) — Other Operating Expenses: 226257.00
ONMD balance_sheet (annual, 2023-12-31) — Other Payable: 3525000.00
ONMD balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Payables: 8207000.00
ONMD balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8207000.00
ONMD balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ONMD cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 16000.00
ONMD income_statement (annual, 2023-12-31) — Pretax Income: -33762000.00
ONMD cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
ONMD cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
ONMD cash_flow (annual, 2023-12-31) — Purchase Of PPE: -44000.00
ONMD balance_sheet (annual, 2023-12-31) — Receivables: 152000.00
ONMD income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1150000.00
ONMD income_statement (annual, 2023-12-31) — Reconciled Depreciation: 28000.00
ONMD cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
ONMD cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
ONMD income_statement (annual, 2023-12-31) — Research And Development: 2065000.00
ONMD balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Retained Earnings: -91440000.00
ONMD income_statement (annual, 2023-12-31) — Salaries And Wages: 3572232.00
ONMD cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
ONMD income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1115000.00
ONMD income_statement (annual, 2023-12-31) — Selling General And Administration: 4659000.00
ONMD balance_sheet (annual, 2023-12-31) — Share Issued: 23572232.00
ONMD cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 6129000.00
ONMD cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
ONMD income_statement (annual, 2023-12-31) — Special Income Charges: -10504327.00
ONMD cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1475000.00
ONMD balance_sheet (annual, 2023-12-31) — Stockholders Equity: -13442000.00
ONMD balance_sheet (annual, 2023-12-31) — Tangible Book Value: -13442000.00
ONMD income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1906380.00
ONMD income_statement (annual, 2023-12-31) — Tax Provision: 18000.00
ONMD income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
ONMD balance_sheet (annual, 2023-12-31) — Total Assets: 464000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Capitalization: -13442000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Debt: 5094000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -13442000.00
ONMD income_statement (annual, 2023-12-31) — Total Expenses: 7874000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 13906000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 99000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 68000.00
ONMD income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -6853000.00
ONMD balance_sheet (annual, 2023-12-31) — Total Tax Payable: 233370.00
ONMD income_statement (annual, 2023-12-31) — Total Unusual Items: -9078000.00
ONMD income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -9078000.00
ONMD balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
ONMD cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ONMD balance_sheet (annual, 2023-12-31) — Working Capital: -13473000.00
ONMD income_statement (annual, 2023-12-31) — Write Off: 10504327.00
ONMD balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6161000.00
ONMD income_statement (quarterly, 2024-09-30) — Basic Average Shares: 29265023.00
ONMD income_statement (quarterly, 2024-09-30) — Basic EPS: -0.07
ONMD cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 6270000.00
ONMD income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 29265023.00
ONMD income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.07
ONMD cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 6270000.00
ONMD cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 6170000.00
ONMD cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: -2331000.00
ONMD balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 28000.00
ONMD cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: -2800000.00
ONMD cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 469000.00
ONMD cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: -700000.00
ONMD income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
ONMD income_statement (annual, 2024-12-31) — +Operating Expense: 9324000.00
ONMD income_statement (annual, 2024-12-31) — +Total Revenue: 643000.00
ONMD balance_sheet (annual, 2024-12-31) — Accounts Payable: 6371000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 6371000.00
ONMD balance_sheet (annual, 2024-12-31) — Accounts Receivable: 213000.00
ONMD balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -216000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -216000.00
ONMD balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 86146000.00
ONMD balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ONMD balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ONMD income_statement (annual, 2024-12-31) — Basic Average Shares: 28076512.00
ONMD income_statement (annual, 2024-12-31) — Basic EPS: -0.36
ONMD cash_flow (annual, 2024-12-31) — Beginning Cash Position: 47000.00
ONMD cash_flow (annual, 2024-12-31) — Capital Expenditure: -51000.00
ONMD cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -35000.00
ONMD balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
ONMD balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 172000.00
ONMD balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3021000.00
ONMD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 9059000.00
ONMD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1982000.00
ONMD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -6952000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Account Payable: 1493000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 307000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Payable: 1493000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1206000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 84000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Receivables: -61000.00
ONMD cash_flow (annual, 2024-12-31) — Change In Working Capital: 1536000.00
ONMD cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -61000.00
ONMD cash_flow (annual, 2024-12-31) — Changes In Cash: 125000.00
ONMD balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
ONMD balance_sheet (annual, 2024-12-31) — Common Stock Equity: -15950000.00
ONMD cash_flow (annual, 2024-12-31) — Common Stock Issuance: 6270000.00
ONMD cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
ONMD cash_flow (annual, 2024-12-31) — Common Stock Payments: -200000.00
ONMD cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -100000.00
ONMD income_statement (annual, 2024-12-31) — Cost Of Revenue: 924000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5703000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 5703000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Assets: 3619000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Debt: 8763000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 8763000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 561000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 561000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Liabilities: 19228000.00
ONMD balance_sheet (annual, 2024-12-31) — Current Notes Payable: 3452000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 3452000.00
ONMD cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 57000.00
ONMD cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 57000.00
ONMD balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 449000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 449000.00
ONMD income_statement (annual, 2024-12-31) — Diluted Average Shares: 28076512.00
ONMD income_statement (annual, 2024-12-31) — Diluted EPS: -0.36
ONMD income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -10129000.00
ONMD income_statement (annual, 2024-12-31) — EBIT: -9980000.00
ONMD income_statement (annual, 2024-12-31) — EBITDA: -9923000.00
ONMD cash_flow (annual, 2024-12-31) — End Cash Position: 172000.00
ONMD cash_flow (annual, 2024-12-31) — Financing Cash Flow: 9059000.00
ONMD cash_flow (annual, 2024-12-31) — Free Cash Flow: -7003000.00
ONMD cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 340000.00
ONMD income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 493000.00
ONMD income_statement (annual, 2024-12-31) — General And Administrative Expense: 7027000.00
ONMD balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 213000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 213000.00
ONMD balance_sheet (annual, 2024-12-31) — Gross PPE: 324000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Gross PPE: 324000.00
ONMD income_statement (annual, 2024-12-31) — Gross Profit: -281000.00
ONMD cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 18000.00
ONMD income_statement (annual, 2024-12-31) — Interest Expense: 147000.00
ONMD income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 147000.00
ONMD cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 26000.00
ONMD balance_sheet (annual, 2024-12-31) — Invested Capital: -7187000.00
ONMD cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1982000.00
ONMD cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 6270000.00
ONMD cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ONMD cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3850000.00
ONMD cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -231000.00
ONMD balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 324000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 324000.00
ONMD cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 6270000.00
ONMD cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -100000.00
ONMD balance_sheet (annual, 2024-12-31) — Net Debt: 8591000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Net Debt: 8591000.00
ONMD income_statement (annual, 2024-12-31) — Net Income: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -10129000.00
ONMD cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -10129000.00
ONMD income_statement (annual, 2024-12-31) — Net Interest Income: -147000.00
ONMD cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -1931000.00
ONMD cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 400000.00
ONMD cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 2889000.00
ONMD cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -231000.00
ONMD income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -147000.00
ONMD cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -100000.00
ONMD cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
ONMD balance_sheet (annual, 2024-12-31) — Net PPE: 108000.00
ONMD cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -51000.00
ONMD cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
ONMD cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
ONMD cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 3120000.00
ONMD balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -15950000.00
ONMD income_statement (annual, 2024-12-31) — Normalized EBITDA: -10416000.00
ONMD income_statement (annual, 2024-12-31) — Normalized Income: -10622000.00
ONMD cash_flow (annual, 2024-12-31) — Operating Cash Flow: -6952000.00
ONMD cash_flow (annual, 2024-12-31) — Operating Gains Losses: 325000.00
ONMD income_statement (annual, 2024-12-31) — Operating Income: -9605000.00
ONMD income_statement (annual, 2024-12-31) — Operating Revenue: 643000.00
ONMD balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 27987427.00
ONMD balance_sheet (annual, 2024-12-31) — Other Current Assets: 385000.00
ONMD balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 5311000.00
ONMD balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 616000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 616000.00
ONMD income_statement (annual, 2024-12-31) — Other Gand A: 7027000.00
ONMD income_statement (annual, 2024-12-31) — Other Income Expense: -375000.00
ONMD cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1429000.00
ONMD balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 449000.00
ONMD balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 449000.00
ONMD income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -868000.00
ONMD income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -299000.00
ONMD balance_sheet (annual, 2024-12-31) — Other Payable: 3585000.00
ONMD balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 2849000.00
ONMD balance_sheet (annual, 2024-12-31) — Payables: 3585000.00
ONMD balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9288000.00
ONMD balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ONMD cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
ONMD cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
ONMD income_statement (annual, 2024-12-31) — Pretax Income: -10127000.00
ONMD cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
ONMD cash_flow (annual, 2024-12-31) — Purchase Of Investment: -2900000.00
ONMD cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -100000.00
ONMD cash_flow (annual, 2024-12-31) — Purchase Of PPE: -51000.00
ONMD balance_sheet (annual, 2024-12-31) — Receivables: 213000.00
ONMD income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 924000.00
ONMD income_statement (annual, 2024-12-31) — Reconciled Depreciation: 57000.00
ONMD cash_flow (annual, 2024-12-31) — Repayment Of Debt: -961000.00
ONMD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -200000.00
ONMD cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -100000.00
ONMD income_statement (annual, 2024-12-31) — Research And Development: 1467000.00
ONMD balance_sheet (annual, 2024-12-31) — Retained Earnings: -101569000.00
ONMD cash_flow (annual, 2024-12-31) — Sale Of Investment: 969000.00
ONMD cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 500000.00
ONMD income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 830000.00
ONMD income_statement (annual, 2024-12-31) — Selling General And Administration: 7857000.00
ONMD balance_sheet (annual, 2024-12-31) — Share Issued: 28175172.00
ONMD cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 3850000.00
ONMD cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -730000.00
ONMD cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: -30000.00
ONMD income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
ONMD cash_flow (annual, 2024-12-31) — Stock Based Compensation: 628000.00
ONMD balance_sheet (annual, 2024-12-31) — Stockholders Equity: -15950000.00
ONMD balance_sheet (annual, 2024-12-31) — Tangible Book Value: -15950000.00
ONMD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (annual, 2024-12-31) — Tax Provision: 2000.00
ONMD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ONMD balance_sheet (annual, 2024-12-31) — Total Assets: 3727000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Capitalization: -15950000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Debt: 8763000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -15950000.00
ONMD income_statement (annual, 2024-12-31) — Total Expenses: 10248000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 19677000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 108000.00
ONMD balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 449000.00
ONMD income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -9605000.00
ONMD income_statement (annual, 2024-12-31) — Total Unusual Items: 493000.00
ONMD income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 493000.00
ONMD balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 187745.00
ONMD balance_sheet (annual, 2024-12-31) — Treasury Stock: 529000.00
ONMD cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -798000.00
ONMD cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -922000.00
ONMD balance_sheet (annual, 2024-12-31) — Working Capital: -15609000.00
ONMD income_statement (quarterly, 2025-03-31) — +Operating Expense: 2000000.00
ONMD income_statement (quarterly, 2025-03-31) — +Total Revenue: 137000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6870000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 247000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 87448000.00
ONMD income_statement (quarterly, 2025-03-31) — Basic Average Shares: 34103724.00
ONMD income_statement (quarterly, 2025-03-31) — Basic EPS: -0.06
ONMD cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 172000.00
ONMD cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 144000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 937000.00
ONMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -94000.00
ONMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1920000.00
ONMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1854000.00
ONMD cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -58000.00
ONMD cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 310000.00
ONMD cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -62000.00
ONMD cash_flow (quarterly, 2025-03-31) — Change In Receivables: -34000.00
ONMD cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 156000.00
ONMD cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -34000.00
ONMD cash_flow (quarterly, 2025-03-31) — Changes In Cash: -28000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -16550000.00
ONMD income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 361000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Assets: 1631000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Debt: 7519000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7519000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 503000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 503000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 18154000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 2195000.00
ONMD cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 12000.00
ONMD cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 12000.00
ONMD income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 34103724.00
ONMD income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.06
ONMD income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — EBIT: -1871000.00
ONMD income_statement (quarterly, 2025-03-31) — EBITDA: -1859000.00
ONMD cash_flow (quarterly, 2025-03-31) — End Cash Position: 144000.00
ONMD cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -94000.00
ONMD cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1859000.00
ONMD cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -852000.00
ONMD income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 190000.00
ONMD income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1362000.00
ONMD income_statement (quarterly, 2025-03-31) — Gross Profit: -224000.00
ONMD cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
ONMD income_statement (quarterly, 2025-03-31) — Interest Expense: 31000.00
ONMD income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 31000.00
ONMD cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 5000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Invested Capital: -9031000.00
ONMD cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 1920000.00
ONMD cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
ONMD cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
ONMD cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -94000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Net Debt: 7375000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1902000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1902000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Interest Income: -31000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -94000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -94000.00
ONMD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -31000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1925000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Net PPE: 101000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5000.00
ONMD cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
ONMD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -16550000.00
ONMD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2049000.00
ONMD income_statement (quarterly, 2025-03-31) — Normalized Income: -2092000.00
ONMD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1854000.00
ONMD cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -852000.00
ONMD income_statement (quarterly, 2025-03-31) — Operating Income: -2224000.00
ONMD income_statement (quarterly, 2025-03-31) — Operating Revenue: 137000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 30572831.00
ONMD balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 447000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 5324000.00
ONMD income_statement (quarterly, 2025-03-31) — Other Gand A: 1362000.00